發表文章
[FDA webinar series]: "Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications (510(k)) with Different Technological Characteristics"
[FDA webinar series]: "Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications (510(k)) with Different Technological Characteristics"
張貼者:
Leo Ou
- 取得連結
- X
- 以電子郵件傳送
- 其他應用程式